$31.90 -0.09 (-0.28%)
2/10/2012 4:00 PM

Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

1
Player Avatar stockdoc00 (24.97) Submitted: 9/14/2008 8:56:03 PM : Outperform Start Price: $18.10 BMY Score: +64.80

As safe as they come in this industry. While it has potential challenges with patent expirations especially with Plavix, it has an underrated pipeline, strong balance sheet and a solid, dependable 5% dividend (hasn't missed a dividend payment in over 50 years!). In this uncertain market, this is stock that you can buy and sleep easy on.

Report this Post Add Comment

Featured Broker Partners


Advertisement